Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
1.765
-0.075 (-4.08%)
At close: Feb 21, 2025, 4:00 PM
1.830
+0.065 (3.68%)
After-hours: Feb 21, 2025, 6:08 PM EST

Company Description

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.

It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.

The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors.

The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024.

Lifeward Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Lifeward Ltd.
Lifeward logo
Country Israel
Founded 2001
IPO Date Sep 12, 2014
Industry Medical Devices
Sector Healthcare
Employees 108
CEO Lawrence Jasinski

Contact Details

Address:
3 Hatnufa Street, Floor 6
Yokneam Illit, 2069203
Israel
Phone 972 4 959 0123
Website golifeward.com

Stock Details

Ticker Symbol LFWD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001607962
ISIN Number IL0011331076
SIC Code 3842

Key Executives

Name Position
Lawrence J. Jasinski BS, MBA Chief Executive Officer and Director
Michael A. Lawless Chief Financial Officer
Miri Pariente Vice President of Operations, Regulatory and Quality
Almog Adar Vice President of Finance and Chief Accounting Officer
Jeannine Lynch Vice President of Market Access and Strategy
Kathleen O'Donnell Vice President of Marketing and New Business Development
Judy Kula Vice President of Customer Service, Human Resources and Business Affairs

Latest SEC Filings

Date Type Title
Feb 20, 2025 8-K Current Report
Feb 14, 2025 EFFECT Notice of Effectiveness
Feb 14, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Feb 11, 2025 S-1 General form for registration of securities under the Securities Act of 1933
Jan 14, 2025 SCHEDULE 13G Filing
Jan 13, 2025 D Notice of Exempt Offering of Securities
Jan 13, 2025 8-K Current Report
Jan 8, 2025 SCHEDULE 13G Filing
Jan 8, 2025 8-K/A [Amend] Current report
Jan 8, 2025 8-K Current Report